1. Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategies
- Author
-
Elena Binda, Nadia Trivieri, Riccardo Ricci, Laura Cajola, Graziano Pesole, Silvia Restelli, Orazio Palumbo, Massimiliano Copetti, Valerio Papa, Fabrizio Giani, Tiziana Latiano, Massimo Carella, Riccardo Pracella, Maria Grazia Cariglia, Angelo L. Vescovi, Dino Amadori, Andrea Arleo, Sergio Alfieri, Antonio Sciuto, Alberto Visioli, Elide Miccinilli, Fabio Dezi, Giulia Gallerani, Visioli, A, Giani, F, Trivieri, N, Pracella, R, Miccinilli, E, Cariglia, M, Palumbo, O, Arleo, A, Dezi, F, Copetti, M, Cajola, L, Restelli, S, Papa, V, Sciuto, A, Latiano, T, Carella, M, Amadori, D, Gallerani, G, Ricci, R, Alfieri, S, Pesole, G, Vescovi, A, Binda, E, Visioli A., Giani F., Trivieri N., Pracella R., Miccinilli E., Cariglia M.G., Palumbo O., Arleo A., Dezi F., Copetti M., Cajola L., Restelli S., Papa V., Sciuto A., Latiano T.P., Carella M., Amadori D., Gallerani G., Ricci R., Alfieri S., Pesole G., Vescovi A.L., and Binda E.
- Subjects
0301 basic medicine ,CRC stem cell ,Research paper ,Colorectal cancer ,Anti-CRC SCs strategies ,CRC biology and biomarkers ,CRC circulating stem cells ,CRC metastatic stem cells ,CRC stem cells ,Human colorectal carcinoma (CRC) ,Stemness ,Fluorescent Antibody Technique ,Loss of Heterozygosity ,CRC metastatic stem cell ,Colorectal Neoplasm ,Disease ,Anti-CRC SCs strategie ,Mice ,0302 clinical medicine ,Circulating tumor cell ,Cell Self Renewal ,DNA Copy Number Variation ,Stemne ,CRC biology and biomarker ,General Medicine ,Neoplastic Cells, Circulating ,Immunohistochemistry ,Cell system ,Cell Transformation, Neoplastic ,030220 oncology & carcinogenesis ,Neoplastic Stem Cells ,Heterografts ,Stem cell ,Heterograft ,Colorectal Neoplasms ,Human ,Epithelial-Mesenchymal Transition ,DNA Copy Number Variations ,Tumor cells ,CRC circulating stem cell ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,medicine ,Animals ,Humans ,Neoplasm Staging ,Settore MED/06 - ONCOLOGIA MEDICA ,Settore MED/08 - ANATOMIA PATOLOGICA ,Animal ,business.industry ,BIO/13 - BIOLOGIA APPLICATA ,Biomarker ,medicine.disease ,Disease Models, Animal ,030104 developmental biology ,Cancer research ,Neoplastic Stem Cell ,Neoplasm Grading ,business ,Biomarkers - Abstract
Background Despite their lethality and ensuing clinical and therapeutic relevance, circulating tumor cells (CTCs) from colorectal carcinoma (CRC) remain elusive, poorly characterized biological entities. Methods and findings We perfected a cell system of stable, primary lines from human CRC showing that they possess the full complement of ex- and in-vivo, in xenogeneic models, characteristics of CRC stem cells (CCSCs). Here we show how tumor-initiating, CCSCs cells can establish faithful orthotopic phenocopies of the original disease, which contain cells that spread into the circulatory system. While in the vascular bed, these cells retain stemness, thus qualifying as circulating CCSCs (cCCSCs). This is followed by the establishment of lesions in distant organs, which also contain resident metastatic CCSCs (mCCSCs). Interpretation Our results support the concept that throughout all the stages of CRC, stemness is retained as a continuous property by some of their tumor cells. Importantly, we describe a useful standardized model that can enable isolation and stable perpetuation of human CRC's CCSCs, cCCSCs and mCCSCs, providing a useful platform for studies of CRC initiation and progression that is suitable for the discovery of reliable stage-specific biomarkers and the refinement of new patient-tailored therapies. Fund This work was financially supported by grants from "Ministero della Salute Italiano"(GR-2011-02351534, RC1703IC36 and RC1803IC35) to Elena Binda and from "Associazione Italiana Cancro" (IG-14368) Angelo L. Vescovi. None of the above funders have any role in study design, data collection, data analysis, interpretation, writing the project.
- Published
- 2019
- Full Text
- View/download PDF